Glycemic control and BMI changes after endoscopic implantation of a duodenojejunal bypass liner compared with laparoscopic Roux-en-Y gastric bypass surgery: a propensity score matching analysis
Authors:
- 4 April 2022
- journal article
- research article
- Published by Springer Nature in Surgical Endoscopy
- Vol. 36 (8) , 5979-5985
Abstract
Introduction Both laparoscopic Roux-en-Y gastric bypass (RYGB) and duodenojejunal bypass liner (DJBL) have been shown to induce weight loss and dramatically ameliorate type 2 diabetes mellitus (T2DM). Since DJBL implantation causes nutrients to pass through the duodenum without contact with the digestive juices and the duodenal mucosa, its mechanisms have been suggested to mimic those of RYGB. This study aimed to compare the outcomes of these two bariatric procedures in terms of glycemic control and BMI in patients with obesity and T2DM. Research design and methods A retrospective observational cohort propensity score-weighted comparison of laparoscopic Roux-en-Y gastric bypass (RYGB) vs duodenojejunal bypass liner (DJBL) was conducted in patients with obesity and T2DM undergoing either procedure from 05/2014 to 12/2017. Propensity scores were weighted for body weight, body mass index (BMI), and glycated hemoglobin A1c (HbA1c). The primary outcome was comparative improvement of HbA1c. Secondary comparative effectiveness outcomes were decrease of body weight and BMI. Results Forty-six patients were included: 21 (10 male, 11 female; mean age 50.6 ± 11.7 years) underwent RYGB, while DJBL was implanted in 25 (10 male, 15 female; 52.5 ± 9.5 years). After twelve months, mean ΔBMI was 11.54 ± 4.47 kg/m2 for RYGB vs. 6.23 ± 2.36 kg/m2 for DJBL (p < 0.05). Mean total weight loss was 27.93 ± 8.57% for RYGB vs. 15.04 ± 5.73% for DJBL (p < 0.05). Glycemic control after one year improved significantly in both groups but did not differ significantly. Conclusion RYGB and DJBL seem to be associated with similar remission rates of hyperglycemia after one year. However, RYGB induces more significant weight loss than DJBL.Keywords
This publication has 21 references indexed in Scilit:
- EndoBarrier® in Grade I Obese Patients with Long-Standing Type 2 Diabetes: Role of Gastrointestinal Hormones in Glucose MetabolismObesity Surgery, 2016
- The impact of EndoBarrier gastrointestinal liner in obese patients with normal glucose tolerance and in patients with type 2 diabetesDiabetes, Obesity and Metabolism, 2016
- Gut-brain mechanisms controlling glucose homeostasisF1000Prime Reports, 2015
- Correlation between Postoperative Weight Loss and Diabetes Mellitus Remission: A Meta-AnalysisObesity Surgery, 2014
- Early improvement in type 2 diabetes mellitus post Roux-en-Y gastric bypass in Asian patients.2010
- Pilot Clinical Study of an Endoscopic, Removable Duodenal-Jejunal Bypass Liner for the Treatment of Type 2 DiabetesDiabetes Technology & Therapeutics, 2009
- The effect of bilio-pancreatic diversion on type 2 diabetes in patients with BMI <35 kg/m2Diabetologia, 2009
- Impact of Different Bariatric Surgical Procedures on Insulin Action and β-Cell Function in Type 2 DiabetesDiabetes Care, 2009
- Mechanism for Improved Insulin Sensitivity after Gastric Bypass SurgeryThe Journal of Clinical Endocrinology & Metabolism, 2008
- Incretin Levels and Effect Are Markedly Enhanced 1 Month After Roux-en-Y Gastric Bypass Surgery in Obese Patients With Type 2 DiabetesDiabetes Care, 2007